Copyright
©The Author(s) 2022.
World J Hepatol. Jun 27, 2022; 14(6): 1099-1110
Published online Jun 27, 2022. doi: 10.4254/wjh.v14.i6.1099
Published online Jun 27, 2022. doi: 10.4254/wjh.v14.i6.1099
Ref. | Patients (n) | Findings | Conclusion |
Wang et al[11], 2020 | 105 | 56.2% of the patients had abnormal ALT, AST, and total bilirubin throughout the course of the disease | Patients with COVID-19 often have abnormal liver function indices |
Fan et al[12], 2020 | 148 | 37.2% had abnormal liver function at hospital admission; 14.5% out of these patients had high fever; patients with abnormal liver function had longer mean hospital stays (15.09 ± 4.79 d) than patients with normal liver function (12.76 ± 4.14 d) | More than one third of SARS-CoV-2 infected patients admitted to hospitals had elevated liver function parameters, which are linked to a prolonged hospital stay |
Ding et al[37], 2021 | 2,073 | Out of 2073 patients, 61.8% showed abnormal liver chemistries during hospitalization, and 14.3% had liver injury | COVID-19-related mortality is predicted by abnormal levels of AST and D-Bil during admission. Infection with HBV does not raise the risk of poor COVID-19-related outcomes in patients |
Cai et al[38], 2020 | 417 | 76.3% had abnormal liver test results and 21.5% had liver injury during hospitalization.ALT, AST, total bilirubin, and gamma-glutamyl transferase levels rose to more than 3 × the upper limit of normal, respectively | The negative effects on liver damage are mostly due to certain drugs taken during hospitalization |
Fan et al[41], 2021 | 288 | Except for AST, the levels of total bilirubin and ALP in normal and severe patients varied within the normal range, with an increasing trend in critical patients | In critical patients, COVID-19 can induce significant hepatic dysfunction, necessitating early monitoring and management. Because of their connection with disease severity in COVID-19, LDH, ALP, GGT, total bilirubin, prealbumin, and albumin may be useful for assessing and predicting disease prognosis |
- Citation: Sahu T, Pande B, PL M, Verma HK. Liver dysfunction during COVID-19 pandemic: Contributing role of associated factors in disease progression and severity. World J Hepatol 2022; 14(6): 1099-1110
- URL: https://www.wjgnet.com/1948-5182/full/v14/i6/1099.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i6.1099